Embrace the new way
GyneConcepts Personal Pap Smear™ at-home pap test for cervical cancer
About GyneConcepts
Changing the Future of Women's Health, One Screening at a Time
At GyneConcepts, we believe every woman deserves access to healthcare that is convenient, affordable, accessible, and comfortable.
For more than three decades, our mission has remained unchanged: To remove barriers that prevent women from receiving the preventive healthcare they need.
That mission led to the development of the Personal Pap Smear™ (PPS)—the world's first patented cervical cell collection device designed to give women a more private and convenient way to participate in cervical health screening. But our story begins long before the PPS. It begins with a simple question.
Why Are Women Still Missing Cervical Cancer Screenings?
For more than 60 years, the Pap smear has helped save millions of lives. It remains one of the most effective tools ever developed for detecting abnormal cervical cells before they become cancerous.
Yet despite its success, hundreds of thousands of women around the world continue to be diagnosed with cervical cancer every year. Many of these cases occur because women never received routine screening.
At GyneConcepts, we wanted to understand why. The answers were remarkably consistent. Women told us:
"It's uncomfortable."
"It's embarrassing."
"It's inconvenient."
"I can't afford it."
"I feel fine."
Others faced barriers related to transportation, scheduling, privacy, cultural beliefs, or limited access to healthcare services.
Slide Title
A brief description for this slide.
Slide Title
A brief description for this slide.
Slide Title
A brief description for this slide.
1 / 3
A Mission Driven by Women's Real Experiences
GyneConcepts was founded on the belief that preventive healthcare should adapt to women's lives—not force women to adapt their lives around healthcare.
Every woman deserves options that respect her schedule, privacy, comfort, and personal circumstances. That belief continues to guide every decision we make.
Our work is centered around one simple goal:
Helping more women benefit from the power of early detection.
When Barriers are Removed, Participation Increases.
When Participation Increases, Lives can be Saved.
Our Journey
November 1994
GyneConcepts was originally incorporated in Arkansas as GyneTech, Inc.
September 1997
The company became GyneConcepts, Inc., reflecting a broader vision for advancing women's healthcare through innovation.
2008
Our principal offices were relocated to Atlanta, Georgia, where we continue to lead research and development efforts focused on improving cervical health screening accessibility.
Today, GyneConcepts remains a privately held, female-led company dedicated to developing technologies that empower women to take a more active role in their preventive healthcare.
Meet the Personal Pap Smear™ (PPS)
The Personal Pap Smear™ represents years of research, innovation, and commitment to addressing one of the biggest challenges in women's healthcare: screening participation.
The PPS is the world's first patented cervical cell collection device designed for self-administration. Women can use the PPS in the privacy of their own home or within a healthcare setting, creating a more flexible and patient-centered experience.
Unlike many self-sampling methods that collect vaginal cells primarily for HPV testing, the PPS is specifically designed to collect cervical cells. These cervical cell samples may be analyzed for: Cervical Cancer, Malignant Cells, Cervical Dysplasia, Yeast Infections, Human papillomavirus (HPV), Chlamydia and HSV ( Herpes Simplex Virus)
By focusing on cervical cell collection while prioritizing convenience and comfort, the PPS reflects our commitment to improving access to preventive care.
Female-Led. Purpose-Driven.
GyneConcepts is proud to be a female-led company. We understand that healthcare decisions are deeply personal and that women often face unique challenges when it comes to preventive care.
Our mission extends beyond technology. We are committed to creating solutions that help women feel more confident, more empowered, and more in control of their health. Everything we do is guided by a simple belief: Women deserve healthcare experiences designed with women in mind.
Leadership
Elizabeth B. Klein
Chief Executive Officer
Elizabeth B. Klein has dedicated her career to leadership, healthcare administration, and community service.
Her professional experience includes leadership roles with KinderCare Learning Centers, where she managed large-scale operations involving site development, construction, financing, and oversight of hundreds of centers and employees.
She also served as Secretary and Treasurer of Medical Associates Hair Transplant Surgery Centers and has been recognized for her commitment to public service through both the Community Service Award for the State of Georgia and the National Jefferson Award for volunteerism.
Since assuming leadership of GyneConcepts in 2008, Elizabeth has continued guiding the company's mission to improve women's healthcare through innovation, accessibility, and compassion.
Phil Klein
Director of Research and Development
Phil Klein is an entrepreneur, healthcare executive, industrial designer, and marketing professional whose vision helped establish the foundation of GyneConcepts.
With decades of experience in advertising, public relations, healthcare practice management, and product development, Phil has played a key role in advancing the company's innovation strategy and intellectual property portfolio.
His background in Fine Arts and Industrial Design continues to influence the thoughtful design and user-focused philosophy behind the Privacy Pap Smear.
Board of Directors
Charlie Lucher
Chief Financial Officer
Dr. Terry Dobson
Director of Investor Relations
Erwin Skibell
Secretary-Treasurer
Kim Gay
Board Member
Dr. James Kern
Chief Medical Advisor
Dr. William Cox
Board of Directors
Marti Henderson
Nurse Practitioner
Innovation Backed by Patents and Certification
The Privacy Pap Smear is supported by a growing portfolio of intellectual property and international recognition.
U.S. Patents
U.S. Patent No. 8,460,209 B2 (Issued June 11, 2013)
U.S. Patent No. 8,672,861 B2 (Issued March 18, 2014)
International Protection
Patent coverage extends across multiple countries and regions, including:
United States, Canada, Australia, New Zealand, South Africa, Russia, United Kingdom, France, Germany, Italy, Netherlands, Spain, Sweden.
CE Registration
In 2016, the Privacy Pap Smear achieved European registration milestones, including Medical Device Registration and In Vitro Device Registration notifications.
These achievements reflect our commitment to innovation, quality, and global accessibility.
Looking Ahead
We envision a future where cervical health screening is no longer limited by inconvenience, embarrassment, cost, or access. A future where more women participate in routine screening. A future where early detection reaches more communities. A future where innovative healthcare solutions help reduce preventable cervical cancer diagnoses worldwide. Through research, clinical evaluation, and continuous innovation, GyneConcepts is working to make that future possible.